These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 9295046

  • 1. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
    Buzyn A, Ostankovitch M, Zerbib A, Kemula M, Connan F, Varet B, Guillet JG, Choppin J.
    Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes.
    Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti E, Butler R, Tanigaki N, Tosi R.
    Leukemia; 1996 Apr; 10(4):693-9. PubMed ID: 8618449
    [Abstract] [Full Text] [Related]

  • 9. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
    Kessler JH, Bres-Vloemans SA, van Veelen PA, de Ru A, Huijbers IJ, Camps M, Mulder A, Offringa R, Drijfhout JW, Leeksma OC, Ossendorp F, Melief CJ.
    Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
    [Abstract] [Full Text] [Related]

  • 10. Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
    Berke Z, Andersen MH, Pedersen M, Fugger L, Zeuthen J, Haurum JS.
    Leukemia; 2000 Mar; 14(3):419-26. PubMed ID: 10720136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S, Luthra R, Cano P.
    BMC Cancer; 2004 Jun 17; 4():25. PubMed ID: 15202948
    [Abstract] [Full Text] [Related]

  • 15. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.
    Posthuma EF, Falkenburg JH, Apperley JF, Gratwohl A, Roosnek E, Hertenstein B, Schipper RF, Schreuder GM, D'Amaro J, Oudshoorn M, van Biezen JH, Hermans J, Willemze R, Niederwieser D.
    Blood; 1999 Jun 01; 93(11):3863-5. PubMed ID: 10339494
    [Abstract] [Full Text] [Related]

  • 16. Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice.
    Casnici C, Volpe G, Crotta K, Lattuada D, Saglio G, Marelli O.
    J Immunother; 2012 May 01; 35(4):321-8. PubMed ID: 22495389
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX, Ripoche J, Pigeonnier V, Jazwiec B, Pigneux A, Moreau JF, Reiffers J.
    Exp Hematol; 1995 Dec 01; 23(14):1606-11. PubMed ID: 8542954
    [Abstract] [Full Text] [Related]

  • 18. Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.
    Gambacorti-Passerini C, Bertazzoli C, Dermime S, Scardino A, Schendel D, Parmiani G.
    Clin Cancer Res; 1997 May 01; 3(5):675-83. PubMed ID: 9815736
    [Abstract] [Full Text] [Related]

  • 19. HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients.
    Rosas-Cabral A, Irigoyen L, Alvarado L, Vela-Ojeda J, Ayala-Sánchez M, Tripp-Villanueva F, Sánchez E, Gonzalez-Llaven J, Gariglio P.
    Rev Invest Clin; 2003 May 01; 55(4):423-8. PubMed ID: 14635607
    [Abstract] [Full Text] [Related]

  • 20. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.
    Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A.
    Blood; 1995 May 15; 85(10):2680-4. PubMed ID: 7742526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.